Form 8.3 - [Abbvie. Inc]
April 08 2020 - 11:09AM
Dow Jones News
TIDM0QCV TIDM0Y7T
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in AbbVie Inc.
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.01 common stock
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 07(th) April 2020
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 68,924,830 4.66757%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 68,924,830 4.66757%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 500 76.16
-------------- ----------------------------- -----------------------
Purchase 200 75.39
-------------- ----------------------------- -----------------------
Purchase 47,500 78.28
-------------- ----------------------------- -----------------------
Purchase 1,526 75.39
-------------- ----------------------------- -----------------------
Purchase 4,500 75.39
-------------- ----------------------------- -----------------------
Purchase 1,400 75.39
-------------- ----------------------------- -----------------------
Purchase 600 75.39
-------------- ----------------------------- -----------------------
Purchase 1,400 75.39
-------------- ----------------------------- -----------------------
Purchase 3,300 75.39
-------------- ----------------------------- -----------------------
Purchase 900 75.39
-------------- ----------------------------- -----------------------
Purchase 3,000 75.39
-------------- ----------------------------- -----------------------
Purchase 32,893 75.39
-------------- ----------------------------- -----------------------
Purchase 3,016 75.39
-------------- ----------------------------- -----------------------
Purchase 960 75.39
-------------- ----------------------------- -----------------------
Purchase 864 75.39
-------------- ----------------------------- -----------------------
Purchase 2,385 75.39
-------------- ----------------------------- -----------------------
Purchase 3,224 75.39
-------------- ----------------------------- -----------------------
Purchase 90 75.39
-------------- ----------------------------- -----------------------
Purchase 51 75.39
-------------- ----------------------------- -----------------------
Purchase 100 77.62
-------------- ----------------------------- -----------------------
Purchase 267 75.39
-------------- ----------------------------- -----------------------
Purchase 267 75.39
-------------- ----------------------------- -----------------------
Purchase 570 75.39
-------------- ----------------------------- -----------------------
Purchase 564 75.39
-------------- ----------------------------- -----------------------
Purchase 684 75.39
-------------- ----------------------------- -----------------------
Sale 66,200 75.39
-------------- ----------------------------- -----------------------
Sale 1,400 75.39
-------------- ----------------------------- -----------------------
Sale 2,500 75.39
-------------- ----------------------------- -----------------------
Sale 100 75.39
-------------- ----------------------------- -----------------------
Sale 331 75.39
-------------- ----------------------------- -----------------------
Sale 900 75.39
-------------- ----------------------------- -----------------------
Sale 5,300 75.39
-------------- ----------------------------- -----------------------
Sale 600 75.39
-------------- ----------------------------- -----------------------
Sale 1,400 75.39
-------------- ----------------------------- -----------------------
Sale 3,300 75.39
-------------- ----------------------------- -----------------------
Sale 14,500 75.39
-------------- ----------------------------- -----------------------
Sale 4,500 75.39
-------------- ----------------------------- -----------------------
Sale 2,900 75.39
-------------- ----------------------------- -----------------------
Sale 25,781 75.39
-------------- ----------------------------- -----------------------
Sale 69,580 75.39
-------------- ----------------------------- -----------------------
Sale 100 75.39
-------------- ----------------------------- -----------------------
Sale 2,506 75.39
-------------- ----------------------------- -----------------------
Sale 970 75.39
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- -----------------
Date of disclosure 08(th) April 2020
------------------------------------------------------- -----------------
Contact name Lionel Colaco
------------------------------------------------------- -----------------
Telephone number 020 33956098
------------------------------------------------------- -----------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- -----------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- -----------------
(END) Dow Jones Newswires
April 08, 2020 10:54 ET (14:54 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Allergan (NYSE:AGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Allergan (NYSE:AGN)
Historical Stock Chart
From Sep 2023 to Sep 2024